Major Depressive Disorder. Major depressive disorder, single episode, severe with psychotic features
Conditions
Interventions
Intervention 1: The intervention group was treated with selective serotonin inhibitors (sertraline, citalopram, fluoxetine and fluoxacin) along with magnesium supplement at a dose of 250 mg per day fo
Sponsors
Ahvaz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: Patients with major depression based on DSM-S and according to the diagnosis of a psychiatrist Age over 18 years Having minimum education to read the questionnaire
Exclusion criteria
Exclusion criteria: Neurological disorders Taking alcohol and drug use during the last 6 months Active suicidal thoughts Pregnancy and lactation Mental retardation Liver and kidney failure Receiving monooxidase inhibitors during the last 8 weeks History of seizures Taking magnesium-interfering drugs Presence of uncontrolled diseases such as diabetes and high blood pressure Allergy to antidepressants or magnesium supplements
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Depression. Timepoint: In weeks 0, 2, 4 6. Method of measurement: Via Beck Depression Inventory. | — |
Secondary
| Measure | Time frame |
|---|---|
| Side effects such as diarrhea. Timepoint: 6 weeks after intervention. Method of measurement: Through questions from the patient. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSusan Sadeghi
Ahvaz University of Medical Sciences
Outcome results
None listed